Insider · CIK 0001741670

Belloff Neil S.

Reports to the SEC for 2 companies · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001741670

Forms 4 and 5

Insider transactions

39 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-03-31	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)A Award	General Counsel and Corp Secy	AAward	+77.3K sh	—	—	77,300
2021-11-08	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)A Award	General Counsel and Corp Secy	AAward	+85K sh	—	—	85,000
2021-07-30	ELOXEloxx Pharmaceuticals, Inc.F Tax Payment	COO, GENERAL COUNSEL &CORP SEC	FTax Payment	−459 sh	$1.32	−$605.88	32,699
2021-07-30	ELOXEloxx Pharmaceuticals, Inc.M Exercise/Conversion	COO, GENERAL COUNSEL &CORP SEC	MExercise/Conversion	+1,563 sh	—	—	33,158
2021-07-30	ELOXEloxx Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	COO, GENERAL COUNSEL &CORP SEC	MExercise/Conversion	−1,563 sh	—	—	9,375
2021-05-25	ELOXEloxx Pharmaceuticals, Inc.M Exercise/Conversion	COO, GENERAL COUNSEL &CORP SEC	MExercise/Conversion	+6,250 sh	—	—	33,430
2021-05-25	ELOXEloxx Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	COO, GENERAL COUNSEL &CORP SEC	MExercise/Conversion	−6,250 sh	—	—	68,750
2021-05-25	ELOXEloxx Pharmaceuticals, Inc.F Tax Payment	COO, GENERAL COUNSEL &CORP SEC	FTax Payment	−1,835 sh	$1.39	−$2,550.65	31,595
2021-04-30	ELOXEloxx Pharmaceuticals, Inc.M Exercise/Conversion	COO, GENERAL COUNSEL &CORP SEC	MExercise/Conversion	+1,562 sh	—	—	27,639
2021-04-30	ELOXEloxx Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	COO, GENERAL COUNSEL &CORP SEC	MExercise/Conversion	−1,562 sh	—	—	10,938
2021-04-30	ELOXEloxx Pharmaceuticals, Inc.F Tax Payment	COO, GENERAL COUNSEL &CORP SEC	FTax Payment	−459 sh	$2.18	−$1,000.62	27,180
2021-02-25	ELOXEloxx Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	COO, GENERAL COUNSEL &CORP SEC	MExercise/Conversion	−25K sh	—	—	75,000
2021-02-25	ELOXEloxx Pharmaceuticals, Inc.M Exercise/Conversion	COO, GENERAL COUNSEL &CORP SEC	MExercise/Conversion	+25K sh	—	—	33,415
2021-02-25	ELOXEloxx Pharmaceuticals, Inc.F Tax Payment	COO, GENERAL COUNSEL &CORP SEC	FTax Payment	−7,338 sh	$3.95	−$29K	26,077
2021-02-12	ELOXEloxx Pharmaceuticals, Inc. · Stock OptionsA Award	COO, GENERAL COUNSEL &CORP SEC	AAward	+120K sh	—	—	120,000
2021-01-30	ELOXEloxx Pharmaceuticals, Inc.M Exercise/Conversion	COO, GENERAL COUNSEL &CORP SEC	MExercise/Conversion	+1,563 sh	—	—	8,957
2021-01-30	ELOXEloxx Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	COO, GENERAL COUNSEL &CORP SEC	MExercise/Conversion	−1,563 sh	—	—	12,500
2021-01-30	ELOXEloxx Pharmaceuticals, Inc.F Tax Payment	COO, GENERAL COUNSEL &CORP SEC	FTax Payment	−542 sh	$3.44	−$1,864.48	8,415
2020-10-30	ELOXEloxx Pharmaceuticals, Inc.F Tax Payment	COO, GENERAL COUNSEL &CORP SEC	FTax Payment	−459 sh	$2.53	−$1,161.27	7,394
2020-10-30	ELOXEloxx Pharmaceuticals, Inc.M Exercise/Conversion	COO, GENERAL COUNSEL &CORP SEC	MExercise/Conversion	+1,562 sh	—	—	7,853
2020-10-30	ELOXEloxx Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	COO, GENERAL COUNSEL &CORP SEC	MExercise/Conversion	−1,562 sh	—	—	14,063
2020-07-30	ELOXEloxx Pharmaceuticals, Inc.M Exercise/Conversion	COO, GENERAL COUNSEL &CORP SEC	MExercise/Conversion	+1,563 sh	—	—	6,750
2020-07-30	ELOXEloxx Pharmaceuticals, Inc.F Tax Payment	COO, GENERAL COUNSEL &CORP SEC	FTax Payment	−459 sh	$2.84	−$1,303.56	6,291
2020-07-30	ELOXEloxx Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	COO, GENERAL COUNSEL &CORP SEC	MExercise/Conversion	−1,563 sh	—	—	15,625
2020-04-30	ELOXEloxx Pharmaceuticals, Inc.F Tax Payment	COO, GENERAL COUNSEL &CORP SEC	FTax Payment	−459 sh	$2.92	−$1,340.28	5,187
2020-04-30	ELOXEloxx Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	COO, GENERAL COUNSEL &CORP SEC	MExercise/Conversion	−1,562 sh	—	—	17,188
2020-04-30	ELOXEloxx Pharmaceuticals, Inc.M Exercise/Conversion	COO, GENERAL COUNSEL &CORP SEC	MExercise/Conversion	+1,562 sh	—	—	5,646
2020-02-25	ELOXEloxx Pharmaceuticals, Inc. · Stock OptionsA Award	COO, GENERAL COUNSEL &CORP SEC	AAward	+200K sh	—	—	200,000
2020-02-25	ELOXEloxx Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	COO, GENERAL COUNSEL &CORP SEC	AAward	+100K sh	—	—	100,000
2020-01-30	ELOXEloxx Pharmaceuticals, Inc.M Exercise/Conversion	COO, GENERAL COUNSEL &CORP SEC	MExercise/Conversion	+6,250 sh	—	—	6,250
2020-01-30	ELOXEloxx Pharmaceuticals, Inc.F Tax Payment	COO, GENERAL COUNSEL &CORP SEC	FTax Payment	−2,166 sh	$3.91	−$8,469.06	4,084
2020-01-30	ELOXEloxx Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	COO, GENERAL COUNSEL &CORP SEC	MExercise/Conversion	+6,250 sh	—	—	18,750
2020-01-30	ELOXEloxx Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	COO, GENERAL COUNSEL &CORP SEC	MExercise/Conversion	−6,250 sh	—	—	18,750
2020-01-30	ELOXEloxx Pharmaceuticals, Inc.F Tax Payment	COO, GENERAL COUNSEL &CORP SEC	FTax Payment	−2,166 sh	$3.91	−$8,469.06	4,084
2020-01-30	ELOXEloxx Pharmaceuticals, Inc.M Exercise/Conversion	COO, GENERAL COUNSEL &CORP SEC	MExercise/Conversion	+6,250 sh	—	—	6,250
2019-09-12	ELOXEloxx Pharmaceuticals, Inc. · Employee Stock Option (Right to Buy)A Award	COO, GENERAL COUNSEL &CORP SEC	AAward	+100K sh	—	—	100,000
2019-01-30	ELOXEloxx Pharmaceuticals, Inc. · Stock OptionsA Award	COO, GENERAL COUNSEL &CORP SEC	AAward	+50K sh	—	—	50,000
2019-01-30	ELOXEloxx Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	COO, GENERAL COUNSEL &CORP SEC	AAward	+25K sh	—	—	25,000
2018-06-18	ELOXEloxx Pharmaceuticals, Inc. · Employee Stock Option (Right to Buy)A Award	COO, GENERAL COUNSEL &CORP SEC	AAward	+125K sh	—	—	125,000

Recent filings

Accepted (ET)
Apr 44
Belloff Neil S.0001209191-23-022749
SEC(opens sec.gov)
Nov 94
Belloff Neil S.0001209191-21-063723
SEC(opens sec.gov)
Jul 304
Belloff Neil S.0001415889-21-003750
SEC(opens sec.gov)
May 264
Belloff Neil S.0001415889-21-002682
SEC(opens sec.gov)
May 34
Belloff Neil S.0001415889-21-002227
SEC(opens sec.gov)
Feb 264
Belloff Neil S.0001415889-21-001001
SEC(opens sec.gov)
Feb 174
Belloff Neil S.0001415889-21-000735
SEC(opens sec.gov)
Feb 24
Belloff Neil S.0001415889-21-000501
SEC(opens sec.gov)
Nov 24
Belloff Neil S.0001415889-20-002520
SEC(opens sec.gov)

Companies

Address

C/O ELOXX PHARMACEUTICALS, INC. 950 WINTER STREET

WALTHAM, MA, 02451